Sommario

• • ·Table of Contents

    Pagina :i

    
• • ·Editorial Board

    Pagina :iv

    
• • ·Information for Readers

    Pagina :v

    

• Curriculum in Cardiology

  • ·The cardiac intensive care unit and the cardiac intensivist during the COVID-19 surge in New York City

    Pagina :74-81

    D. Edmund Anstey, Raymond Givens, Kevin Clerkin, Justin Fried, Nellie Kalcheva, Deepa Kumaraiah, Amirali Masoumi, Daniel O'Connor, Gregg F. Rosner, Lauren Wasson, Jeffrey Hammond, Ajay J. Kirtane, Nir Uriel, Allan Schwartz, LeRoy E. Rabbani, Marwah Abdalla

    Riassunto Riassunto Mappa Mappa  

• Trial Designs

  • ·North American COVID-19 ST-Segment-Elevation Myocardial Infarction (NACMI) registry: Rationale, design, and implications

    Pagina :11-18

    Payam Dehghani, Laura J. Davidson, Cindy L. Grines, Keshav Nayak, Jacqueline Saw, Prashant Kaul, Akshay Bagai, Ross Garberich, Christian Schmidt, Hung Q. Ly, Jay Giri, Perwaiz Meraj, Binita Shah, Santiago Garcia, Scott Sharkey, David A. Wood, Frederick G. Welt, Ehtisham Mahmud, Timothy D. Henry

    Riassunto Riassunto Mappa Mappa   
  • ·Rationale and design of the RIGHT trial: A multicenter, randomized, double-blind, placebo-controlled trial of anticoagulation prolongation versus no anticoagulation after primary percutaneous coronary intervention for ST-segment elevation myocardial infarction

    Pagina :19-30

    Yan Yan, Xiao Wang, Jincheng Guo, Yongjun Li, Hui Ai, Wei Gong, Bin Que, Lei Zhen, Jiapeng Lu, Changsheng Ma, Gilles Montalescot, Shaoping Nie

    Riassunto Riassunto Mappa Mappa  
  • ·Accelerated treatment of endocarditis—The POET II trial: Rationale and design of a randomized controlled trial

    Pagina :40-46

    Lauge Østergaard, Mia Marie Pries-Heje, Rasmus Bo Hasselbalch, Magnus Rasmussen, Per Åkesson, Robert Horvath, Jonas Povlsen, Sabine Gill, Niels Eske Bruun, Katrine Müllertz, Christian Ditlev Tuxen, Nikolaj Ihlemann, Jannik Helweg-Larsen, Claus Moser, Emil Loldrup Fosbøl, Henning Bundgaard, Kasper Iversen

    Riassunto Riassunto Mappa Mappa   
  • ·China Tongxinluo Study for myocardial protection in patients with Acute Myocardial Infarction (CTS-AMI): Rationale and design of a randomized, double-blind, placebo-controlled, multicenter clinical trial

    Pagina :47-55

    Yi Xu, Xiangdong Li, Haitao Zhang, Yuan Wu, Jun Zhang, Jia Li, Kefei Dou, Hongbing Yan, Shijie You, Yanmin Yang, Yan Liang, Lianjun Xu, Xiaojin Gao, Chen Liu, Qiuting Dong, Wenjia Zhang, Guangyuan Song, Tao Zhang, Lin Jiang, Guihao Chen, Ruijie Tang, Chen Jin, Jingang Yang, Chen Yao, Ying Xian, Eric D. Peterson, Runlin Gao, Yuejin Yang

    Riassunto Riassunto Mappa Mappa  
  • ·A multinational registry to study the characteristics and outcomes of heart failure patients: The global congestive heart failure (G-CHF) registry

    Pagina :56-63

    Philip Joseph, Hisham Dokainish, Tara McCready, Andrzej Budaj, Ambuj Roy, Georg Ertl, Juan Esteban Gomez-Mesa, Darryl Leong, Justin Ezekowitz, Camilla Hage, Fernando Lanas, Aldo P. Maggioni, Karen Sliwa, Jun Zhu, Jean Rouleau, Kumar Balasubramanian, Salim Yusuf, G-CHF Investigators

    Riassunto Riassunto Mappa Mappa   
  • ·Rationale and design of PROACT Xa: A randomized, multicenter, open-label, clinical trial to evaluate the efficacy and safety of apixaban versus warfarin in patients with a mechanical On-X Aortic Heart Valve

    Pagina :91-99

    Oliver K. Jawitz, Tracy Y. Wang, Renato D. Lopes, Alma Chavez, Brittanny Boyer, Hwasoon Kim, Kevin J. Anstrom, Richard C. Becker, Eugene Blackstone, Marc Ruel, Vinod H. Thourani, John D. Puskas, Marc W. Gerdisch, Douglas Johnston, Scott Capps, John H. Alexander, Lars G. Svensson

    Riassunto Riassunto Mappa Mappa   
  • ·Rationale and design for the study Apixaban versus ClopidoGRel on a background of aspirin in patient undergoing InfraPoPliteal angioplasty for critical limb ischemia: AGRIPPA trial

    Pagina :100-106

    Rodrigo Bruno Biagioni, Renato Delascio Lopes, Leandro Barile Agati, Roberto Sacilotto, Nelson Wolosker, Marcone Lima Sobreira, Bruno Leonardo de Freitas Soares, Edwaldo Edner Joviliano, Walkiria Hueb Bernardi, Valter Castelli Junior, Roberto Augusto Caffaro, Alexandre Fioranelli, Bonno Van Bellen, Ivan Benaduce Casella, Ronald José Ribeiro Fidelis, Ronald Luiz Gomes Flumignan, Anthony James Comerota, Eduardo Ramacciotti

    Riassunto Riassunto Mappa Mappa  
  • ·Percutaneous complete revascularization strategies using sirolimus-eluting biodegradable polymer-coated stents in patients presenting with acute coronary syndrome and multivessel disease: Rationale and design of the BIOVASC trial

    Pagina :111-117

    Wijnand K. den Dekker, Nicolas M. Van Mieghem, Johan Bennett, Manel Sabate, Giovanni Esposito, Rutger J. van Bommel, Joost Daemen, Matthias Vrolix, Paul A. Cummins, Mattie J. Lenzen, Eric Boersma, Felix Zijlstra, Roberto Diletti, on Behalf of the BioVasc Trial Investigators

    Riassunto Riassunto Mappa Mappa  

• Clinical Investigations

  • ·The utility of risk scores when evaluating for acute myocardial infarction using high-sensitivity cardiac troponin I

    Pagina :1-8

    Joseph Gibbs, Christopher deFilippi, Frank Peacock, Simon Mahler, Richard Nowak, Robert Christenson, Fred Apple, Gordon Jacobsen, James McCord

    Riassunto Riassunto Mappa Mappa  
  • ·A randomized controlled trial of lung ultrasound-guided therapy in heart failure (CLUSTER-HF study)

    Pagina :31-39

    Diego Araiza-Garaygordobil, Rodrigo Gopar-Nieto, Pablo Martinez-Amezcua, Alejandro Cabello-López, Gabriela Alanis-Estrada, Abraham Luna-Herbert, Héctor González-Pacheco, Cynthia Paola Paredes-Paucar, Martinez Daniel Sierra-Lara, Jose Luis Briseño-De la Cruz, Hugo Rodriguez-Zanella, Marco Antonio Martinez-Rios, Alexandra Arias-Mendoza

    Riassunto Riassunto Mappa Mappa   
  • ·Modifiable lifestyle factors and heart failure: A Mendelian randomization study

    Pagina :64-73

    Sabine van Oort, Joline W.J. Beulens, Adriana J. van Ballegooijen, M. Louis Handoko, Susanna C. Larsson

    Riassunto Riassunto Mappa Mappa   
  • ·P2Y12 inhibitor monotherapy versus aspirin monotherapy after short-term dual antiplatelet therapy for percutaneous coronary intervention: Insights from a network meta-analysis of randomized trials

    Pagina :82-90

    Toshiki Kuno, Hiroki Ueyama, Hisato Takagi, Sripal Bangalore

    Riassunto Riassunto Mappa Mappa   

• Research Letters

  • ·Percutaneous coronary intervention or coronary artery bypass graft surgery for left main coronary artery disease: A meta-analysis of randomized trials

    Pagina :9-10

    Toshiki Kuno, Hiroki Ueyama, Sunil V. Rao, Mauricio G. Cohen, Jacqueline E. Tamis-Holland, Craig Thompson, Hisato Takagi, Sripal Bangalore

    Riassunto Riassunto Mappa Mappa  
  • ·Exploring payments in the US pharmaceutical market from 2011 to 2019: Update on pharmacy benefit manager impact

    Pagina :107-110

    Emery P. Weinstein, Kevin Schulman

    Riassunto Riassunto Mappa Mappa